| Table 3. Embryology outcomes | ||||
| Embryology outcomes | Overall | (+) Dominant follicle | (-) Dominant follicle | p- value* |
|---|---|---|---|---|
| Number of oocytes [range per patient] | 239 [4–42] | 115 [4–42] | 124 [4–15] | - |
| Number of mature oocytes after IVM | 164 | 80 | 84 | - |
| Percentage of mature oocytes, per cycle (mean±SD) | 69.3±23.8% | 69.7±16.2% | 69.0±27.9% | 0.8257 |
| Percentage of fertilized oocytes, per cycle (mean±SD) | 88.8±15.2% | 82±14.3% | 92.9±14.6% | 0.0454 |
| Percentage of usable blastocyst/fertilized oocyte (mean±SD) | 37.7±28.3% | 20.5±19.1% | 48.0±28.3% | 0.0161 |
| Percentage of usable blastocyst/MII oocyte (mean±SD) | 34.3±28.5% | 16.4±15% | 45.0±29.6% | 0.0076 |
| Percentage of usable blastocyst/COC (mean±SD) | 21.9±20.6% | 10.6±10.6% | 28.7±22.5% | 0.0217 |
| * Statistical calculations were performed to compare the outcomes of patients in which a dominant follicle was present (+) or absent (-) | ||||